Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,490
Closed -$898K 103
2016
Q2
$898K Sell
6,490
-410
-6% -$53.2K 0.04% 337
2016
Q1
$870K Sell
6,900
-890
-11% -$113K 0.03% 345
2015
Q4
$988K Buy
+7,790
New +$967K 0.03% 332
2015
Q3
Sell
-57,542
Closed -$5.99M 266
2015
Q2
$5.99M Buy
57,542
+38,247
+198% +$4.13M 0.12% 221
2015
Q1
$2.13M Sell
19,295
-100,104
-84% -$10.9M 0.04% 271
2014
Q4
$12.4M Buy
119,399
+6,209
+5% +$621K 0.12% 168
2014
Q3
$10.9M Buy
113,190
+13,530
+14% +$1.22M 0.08% 235
2014
Q2
$9.11M Buy
+99,660
New +$8.93M 0.06% 278
2014
Q1
Sell
-79,590
Closed -$7.38M 412
2013
Q4
$7.38M Buy
+79,590
New +$7.17M 0.06% 283
2013
Q3
Sell
-63,090
Closed -$5.25M 482
2013
Q2
$5.25M Buy
+63,090
New +$5.43M 0.07% 288

Other funds holding CLX

Euclid Advisors's CLX Position: Q3 2016 in Review

Euclid Advisors sold out of Clorox (CLX) in Q3 2016, closing a stake of 6,490 shares — an estimated $898K sold.

Euclid Advisors first reported a position in CLX in Q2 2013 and held it in 10 quarters. The position peaked at $12.4M in Q4 2014. 823 funds tracked by Wall St. Rank hold CLX as of Q3 2016.

  • Euclid Advisors reported no remaining Clorox position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 6,490 Clorox shares in Q3 2016, an estimated $898K.
  • Euclid Advisors first reported a position in Clorox in Q2 2013 and held it in 10 quarters.
  • Euclid Advisors's Clorox position peaked at $12.4M in Q4 2014.
  • 823 funds tracked by Wall St. Rank held Clorox as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.